OM:NOLA B
OM:NOLA BIndustrials

Insider Action On 3 Undervalued Small Caps In Global Market

In recent weeks, global markets have shown resilience, with small-cap indices like the Russell 2000 and S&P MidCap 400 outperforming their large-cap counterparts amid easing U.S. inflation and strong business activity indicators. In this environment, identifying promising small-cap stocks often involves looking for companies with solid fundamentals that can capitalize on economic trends and navigate market volatility effectively.
OM:SWEC B
OM:SWEC BConstruction

Sweco (OM:SWEC B) Earnings Beat: Margin Growth Reinforces Optimistic Market Narratives

Sweco (OM:SWEC B) reported earnings growth of 14.2% over the past year, building on a 10% annual earnings growth rate over the past five years. Net profit margins reached 6.9%, up from 6.2% a year ago, and revenue is forecast to accelerate at 6.8% per year, outpacing the broader Swedish market’s 3.7% estimate. As investors digest these strong fundamentals, Sweco’s above-average valuation multiples and only minor risk regarding dividend sustainability may shape the market’s response to the...
OM:EPI A
OM:EPI AMachinery

Epiroc (OM:EPI A) Margin Slip Raises Questions on Premium Valuation Versus Growth Outlook

Epiroc (OM:EPI A) delivered mixed earnings, with forecasts pointing to 8.57% annual EPS growth and revenue expected to rise 4.8% per year, ahead of the Swedish market’s 3.7% revenue forecast. However, net profit margins slipped to 13.6% from 13.9% a year ago, and the company posted negative earnings growth over the past 12 months, breaking a streak of 9.7% average annual EPS growth over the previous five years. While projected growth hints at underlying business momentum, profit growth is set...
OM:BINV
OM:BINVBiotechs

BioInvent (OM:BINV) Revenue Growth Forecast Tops Market Expectations, Reinforcing Bullish Outlook

BioInvent International (OM:BINV) reported another year of unprofitability, with net losses growing at an annual rate of 27.2% over the past five years. Notably, the company is forecast to turn things around, as earnings are expected to jump 57.17% annually and BioInvent is projected to become profitable within the next three years. Investors are eyeing the strong revenue growth outlook as a potential catalyst, with the pace set to outstrip the broader market and support a constructive...
OM:INTRUM
OM:INTRUMCommercial Services

Intrum (OM:INTRUM): Losses Worsen at 43% Annual Rate, Challenging Bullish Profitability Forecasts

Intrum (OM:INTRUM) has seen its losses deepen over the past five years, with net losses increasing at a rate of 43.3% per year. Meanwhile, revenue is projected to grow at just 0.1% per year, falling behind the broader Swedish market’s expected 3.7% annual growth. Looking ahead, the company is expected to return to profitability within the next three years, with earnings forecast to grow 3.27% per year, which is considered an above-average outlook compared to market peers. See our full...
NGM:GTAB B
NGM:GTAB BMedical Equipment

European Penny Stocks To Watch In October 2025

As European markets continue to show resilience, with major indices such as the STOXX Europe 600 Index and Germany's DAX posting gains, investors are keenly observing opportunities in various sectors. Penny stocks, although an older term, remain relevant for those seeking value in smaller or less-established companies that may offer significant growth potential. By focusing on robust financials and clear growth prospects, these stocks can present a compelling opportunity for investors looking...